The Role of Intestinal Barrier Function in Early Life in the Development of Colitis

QR Code

The Role of Intestinal Barrier Function in Early Life in the Development of Colitis

None

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Anderson, R.C., Dalziel, J.E., Gopal, P.K., Bassett, S., Ellis, A., Roy, N.C.
Hōputu:	Tāhiko Wāhanga pukapuka
Reo:	Ingarihi
I whakaputaina:	IntechOpen 2012
Ngā marau:	Health Sciences
Urunga tuihono:	https://www.intechopen.com/chapters/25358
Tags:	Tāpirihia he Tūtohu No Tags, Be the first to tag this record!

Ngā tūemi rite

The Roles of Interleukin-17 and T Helper 17 Cells in Intestinal Barrier Function
mā: Trusevych, Elizabeth, me ētahi atu.
I whakaputaina: (2012)

Gegen Qinlian Decoction Ameliorated DSS-Induced Colitis by Attenuating Inflammation, Restoring Intestinal Mucosal Barrier and Modulating Gut Microbiota
mā: Wang Y, me ētahi atu.
I whakaputaina: (2025-06-01)

Ulcerative Colitis but Not Dextran Sodium Sulfate–Induced Colitis–Associated Microbiota Promotes Early Biomarkers of Colitis in Interleukin-10 −/− Mice
mā: Kayla Roy, me ētahi atu.
I whakaputaina: (2025-01-01)

Protective bioactivity of Ziziphus jujuba dates polysaccharide on colitis via improving the intestinal barrier and modifying the gut microbiota
mā: Qiaoying Song, me ētahi atu.
I whakaputaina: (2025-09-01)

In Vitro Co-culture of Bacterial and Mammalian Cells to Investigate Effects of Potential Probiotics on Intestinal Barrier Function
mā: Ajitpal Purba, me ētahi atu.
I whakaputaina: (2025-06-01)

Intestinal Barrier, Permeability and Nonspecific Inflammation in Functional Gastrointestinal Disorders
mā: A. L. Kovaleva, me ētahi atu.
I whakaputaina: (2020-09-01)

Therapeutic effects of Lacticaseibacillus paracasei PC-H1 in alleviating colitis through restoring intestinal barrier and regulating gut microbiota
mā: Guoding Cao, me ētahi atu.
I whakaputaina: (2025-09-01)

Role of the Barrier Dysfunction of the Intestines in the Development of Alimentary Allergy in Children
mā: T. E. Borovik, me ētahi atu.
I whakaputaina: (2013-03-01)

Intestinal barrier and dermatological diseases
mā: V. A. Okhlopkov, me ētahi atu.
I whakaputaina: (2021-06-01)

Damage on intestinal barrier function and microbial detoxification of deoxynivalenol: A review
mā: Jia Chen, me ētahi atu.
I whakaputaina: (2024-08-01)

Probiotic <i>Lacticaseibacillus paracasei</i> E10 Ameliorates Dextran Sulfate Sodium-Induced Colitis by Enhancing the Intestinal Barrier and Modulating Microbiota
mā: Yuanyuan Dai, me ētahi atu.
I whakaputaina: (2025-07-01)

Flow Through Porous Media Induced by an Impervious Rotating Disk in the Presence of Magnetic Field
mā: P.K. SHARMA, me ētahi atu.
I whakaputaina: (2005-03-01)

Bile acids affect intestinal barrier function through FXR and TGR5
mā: Guangyao Song, me ētahi atu.
I whakaputaina: (2025-07-01)

The Improvement of Intestinal Mucosal Epithelial Barrier Integrity by 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-d]pyridazinone in Rat Experimental Colitis
mā: Szandruk-Bender M, me ētahi atu.
I whakaputaina: (2025-07-01)

HMGB1 Exacerbates Intestinal Barrier Damage by Inducing Ferroptosis Through the TLR4/NF-κB/GPX4 Pathway in Ulcerative Colitis
mā: Nannan Zhu, me ētahi atu.
I whakaputaina: (2025-01-01)

Lyophyllum decastes-derived polysaccharides alleviate DSS-induced colitis in mice by suppressing inflammation, enhancing intestinal barrier integrity, and restoring gut microbiota homeostasis
mā: Eslam Ghaleb, me ētahi atu.
I whakaputaina: (2025-07-01)

ADHESION MOLECULES IN INTESTINAL DESTRUCTIVE-INFLAMMATORY PROCESS IN THE CHILDREN WITH ULCERATIVE COLITIS
mā: V. I. Ashkinazi, me ētahi atu.
I whakaputaina: (2013-07-01)

Food and Intestinal Microorganisms: Factors in Pathogenesis, Prevention and Therapy of Ulcerative Colitis
mā: Orel, Rok, me ētahi atu.
I whakaputaina: (2011)

Intestinal Barrier Dysfunction: The Primary Driver of IBD?
mā: Hindryckx, Pieter, me ētahi atu.
I whakaputaina: (2012)

The impact of active components from on the growth, intestinal barrier function, and immunity of broiler chickens
mā: Luli Zhou, me ētahi atu.
I whakaputaina: (2025-07-01)

Ulcerative Colitis and Pregnancy
mā: Alakkari, A., me ētahi atu.
I whakaputaina: (2011)

Mucosal barrier function and microbial community of small intestines in sheep in response to dietary energy concentrations
mā: X.L. Wang, me ētahi atu.
I whakaputaina: (2025-07-01)

Serological Markers of Intestinal Barrier Function and Inflammation as Potential Predictors of Recurrent Primary Sclerosing Cholangitis
mā: Hlavaty M, me ētahi atu.
I whakaputaina: (2025-07-01)

Retinol is involved in the intestinal regeneration and strengthens the intestinal barrier during refeeding in broiler chickens
mā: Youli Wang, me ētahi atu.
I whakaputaina: (2024-11-01)

The Role of the Microbiome and Intestinal Mucosal Barrier in the Development and Progression of Non-Alcoholic Fatty Liver Disease
mā: T. S. Krolevets, me ētahi atu.
I whakaputaina: (2020-12-01)

Intramuscular iron supplementation enhances intestinal barrier function in weaned piglets challenged with enterotoxigenic Escherichia coli
mā: Chenying Tian, me ētahi atu.
I whakaputaina: (2025-07-01)

Functional-morphological changes in small intestine in early post-resuscitation period
mā: T. P. Konyaeva, me ētahi atu.
I whakaputaina: (2004-06-01)

The Role of COX-2 Inhibitors on Experimental Colitis
mā: Paiotti, Ana Paula R., me ētahi atu.
I whakaputaina: (2012)

IL-17A as a Key Mediator of Pulmonary-Intestinal Immune Interactions in a Mouse Model of Asthma and Colitis
mā: Wu C, me ētahi atu.
I whakaputaina: (2025-06-01)

Wuda Granule Alleviates DSS-Induced Colitis in Mice by Inhibiting Inflammation, Protecting Intestinal Barrier and Reducing Oxidative Stress Through Nrf2/Keap1/HO-1 Pathway
mā: Wang T, me ētahi atu.
I whakaputaina: (2025-06-01)

Core gut microbiota in rabbit: opportunities to strengthen the intestinal barrier
mā: Sylvie Combes, me ētahi atu.
I whakaputaina: (2025-06-01)

Soluble Siglec-9 Improves Intestinal Barrier Function in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis
mā: Hisanori Muto, me ētahi atu.
I whakaputaina: (2025-05-01)

Monochromatic Light Impacts the Growth Performance, Intestinal Morphology, Barrier Function, Antioxidant Status, and Microflora of Yangzhou Geese
mā: Gang Luo, me ētahi atu.
I whakaputaina: (2025-06-01)

PSYCHOLOGICAL ASPECTS OF QUALITY OF LIFE AND PROGNOSIS OF REHABILITATION IN PATIENTS WITH ULCERATIVE COLITIS
mā: T. E. Chernyshova, me ētahi atu.
I whakaputaina: (2020-11-01)

Bifidobacterium bifidum CCFM1389 Regulates Intestinal Motility Disorder by Repairing the Enteric Nervous System and Intestinal Barrier
mā: HUANG Yin, LI Jiazhen, LIU Wenxu, XUE Yifan, ZHU Shengnan, WANG Linlin, WANG Gang
I whakaputaina: (2025-07-01)

Amebic Colitis
mā: Isea, María Carolina, me ētahi atu.
I whakaputaina: (2012)

Ulcerative Colitis
mā: Ajlouni, Yousef, me ētahi atu.
I whakaputaina: (2012)

Ulcerative Colitis
mā: Ahmed, Iftikhar, me ētahi atu.
I whakaputaina: (2011)

Colitis microscópica
mā: Jorge Luís Bauta Desdín, me ētahi atu.
I whakaputaina: (2017-05-01)

Induction of intestinal barrier dysfunction in dairy heifers: Evaluation of new serum inflammatory markers and method for quantifying intestinal hyperpermeability
mā: K.E. Vagnoni, me ētahi atu.
I whakaputaina: (2025-07-01)